Castle Biosciences, Inc. (CSTL)
27.72
-0.27
(-0.96%)
USD |
NASDAQ |
Mar 03, 14:38
Castle Biosciences Shareholders Equity (Quarterly) : 470.87M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 540.72M |
| Delcath Systems, Inc. | 111.22M |
| Assertio Holdings, Inc. | 105.80M |
| CorMedix, Inc. | 374.13M |
| Harmony Biosciences Holdings, Inc. | 870.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 609.21M |
| Total Liabilities (Quarterly) | 138.34M |
| Debt to Equity Ratio | 0.0786 |
| Current Ratio | 5.258 |
| Net Debt Paydown Yield | -0.18% |